GGrantIndex
← Leaderboards

University Of Tennessee Health Sci Ctr

Memphis, TN

Compare ↔
$1,092,807,245
Total funding
1,038
Grants

Funding over time

peak $69.7M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,081,072,528 · 1026
AHRQ$6,316,543 · 7
CDC$3,002,398 · 1
FDA$2,415,776 · 3
SAMHSA$0 · 1

By mechanism

R01$722,586,235 · 445
U01$96,623,847 · 28
R21$44,859,838 · 122
U19$31,995,658 · 13
UC6$17,779,800 · 1
R37$15,423,335 · 5

Investigators at University Of Tennessee Health Sci Ctr

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1David George Ashbrook$2,351,6811 gr2Satya Surbhi$2,127,5011 gr3Joseph Wilson Jackson$1,453,9731 gr4Bob Mack Moore$1,121,9631 gr5Jacen Shannon Moore$1,039,1811 gr6Morgan Craig$878,6421 gr7John Vincent Cox$782,7951 gr8Sue Chin Lee$778,5211 gr

Emerging Leaders

6–10 yrs in

1Karen J Derefinko$6,695,5904 gr2Megan Kathleen Mulligan$3,609,2874 gr3Brendan Tunstall$3,603,8733 gr4Ramesh Narayanan$3,467,0122 gr5Tobias Elze$3,166,3323 gr6Amali Samarasinghe$3,148,3582 gr7Keiichi Sumida$3,138,4552 gr8Siamak Yousefi$2,924,1604 gr

All-Time

Most funded here, all years

1Gadiparthi N Rao$27,893,7156 gr2Yi Zheng$25,507,49425 gr3Jonathan H Jaggar$19,968,82110 gr4James Martin Krueger$18,942,1975 gr5Kafait U Malik$17,227,4112 gr6Gabor J Tigyi$16,722,25710 gr7Ming D Li$15,975,6085 gr8Dalton James Surmeier$15,589,6808 gr

Largest grants

Biocontainment Laboratory/Biodefense/Infectious Disease$13,767,463
UC6 · FY2003 · AI
Center of Excellence for Encephalitic Alphavirus Therapeutics$5,781,676
U19 · FY2022 · AI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$5,425,184
U19 · FY2023 · AI
Center of Excellence for Encephalitic Alphavirus Therapeutics$5,108,171
U19 · FY2021 · AI
In Vitro Evaluation and Characterization of Novel Lead Therapeutic Candidates for Encephalitic Alphavirus Treatment$4,612,067
U19 · FY2022 · AI
Biocontainment Laboratory/Biodefense/Infectious Disease$4,012,337
UC6 · FY2005 · AI
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,723,013
U19 · FY2019 · AI
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,469,631
U19 · FY2020 · AI
UTHSC Regional Biocontainment Laboratory: Upgrade of Facility and Building System$3,211,742
G20 · FY2021 · AI
Radiobiology Research Suite Expansion of the TriMetis GLP Vivarium at UTHSC$3,115,346
C06 · FY2021 · OD
TARGETED MUTAGENESIS OF MOUSE GENOME &NEURAL PHENOTYPE$3,079,297
U01 · FY2004 · MH
Mapping genetic vulnerability to oxidative stress in development and its consequences in age-associated cognitive decline using a novel reduced complexity rat model$3,078,607
RF1 · FY2025 · AG
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,021,825
U19 · FY2023 · AI
Mitoprotective therapies for kidney injury$3,010,432
R01 · FY2025 · DK
TARGETED MUTAGENESIS OF MOUSE GENOME &NEURAL PHENOTYPE$2,995,022
U01 · FY2003 · MH
TARGETED MUTAGENESIS OF MOUSE GENOME &NEURAL PHENOTYPE$2,903,451
U01 · FY2002 · MH
TARGETED MUTAGENESIS OF MOUSE GENOME &NEURAL PHENOTYPE$2,702,265
U01 · FY2001 · MH
Novel mechanistic link between metabolic changes and dementia - potential role of miRNAs$2,662,493
RF1 · FY2018 · AG
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$2,565,790
U19 · FY2021 · AI
TARGETED MUTAGENESIS OF MOUSE GENOME &NEURAL PHENOTYPE$2,489,464
U01 · FY2000 · MH